Prior studies of the association between socioeconomic status and length of survival among persons infected with the human immunodeficiency virus (HIV) have produced conflicting results. To investigate this issue further, the authors examined data on 18,167 San Francisco, California, residents aged 13 years or older who were diagnosed with acquired immunodeficiency syndrome (AIDS) between January 1, 1985, and December 31,1995. Three validated US census-based measures of socioeconomic status were used: poverty, predominantly working class neighborhood, and low educational level. Median length of survival was found to be similar for persons living in neighborhoods characterized by poverty (22 months) and those in higher income neighbortioods (23 months), for persons living in predominantly working class neighborhoods (22 months) and 'those in predominantly professional/managerial neighborhoods (23 months), and for persons living in neighborhoods characterized by low educational level (23 months) and those in neighborhoods characterized by higher educational level (23 months). After adjustment for sex, age, ethnicity, AIDS risk group, site of AIDS diagnosis, time period of AIDS diagnosis, and AIDS-indicator illness, no association was found between survival and living in a neighborhood characterized by poverty (relative hazard (RH) = 1.03, 95% confidence interval (CO 0.97-1.08), between survival and working class occupations (RH = 1.03, 95% Cl 0.98-1.08), or between survival and low educational level (RH = 0.96, 95% Cl 0.90-1.01). The lack of an association between socioeconomic status and length of survival with AIDS may be due to the high mortality from AIDS in the era prior to highly effective antiretroviral therapy or to similar levels of access to care in San Francisco. Am J Epidemiol 1998; 148:282-91.
persons diagnosed with AIDS in Philadelphia, Pennsylvania, found that lower income was associated with shorter survival, but the differences were statistically significant only among adult males. A study of 1,372 patients seen at the Johns Hopkins HTV Clinic in Baltimore, Maryland, showed that income had no effect on survival (7) .
Many studies have examined the relation between HTV/AEDS survival and proxies of low socioeconomic status, specifically, ethnic minority status, sex, and injection drug use. These studies have also produced conflicting results. The majority have found a shorter period of survival among ethnic minorities (8) (9) (10) (11) (12) , but not all have supported this relation (7, 13) . Some studies have found that women have a shorter survival period than men do (10, 12) ; other studies report that women have a similar or longer period of survival (7, (14) (15) (16) (17) (18) . Similarly, some studies have shown that survival for injection drug users is shorter (10, 12) ; other studies have not found this to be true (7, 16, (18) (19) (20) .
One reason for the conflicting results is that the relation between socioeconomic status and length of survival is mediated by a variety of factors that have differed in these studies. For example, access to med-ical care and treatment has been shown to be associated with improved length of survival among HTVinfected persons (7-9, 14, 16, 21) . Levels of access to treatment are known to be lower among persons of a lower socioeconomic status, especially the uninsured (8, (22) (23) (24) (25) . Of the four studies specifically examining socioeconomic status and HTV/AIDS survival, all subjects in the Vancouver cohort were covered by Canada's universal health insurance and had access to antiretroviral and prophylactic medications (4, 5) . Persons with AIDS from Philadelphia (6) and those seen at the HTV clinic in Baltimore (7) had various levels of insurance coverage and access to treatment.
Receipt of care from a clinician experienced in treating HIV has been shown to be associated with improved length of survival (26) . Participants in the Vancouver cohort (4, 5) and those at the HTV clinic in Baltimore (7) all received care at HTV specialty centers, while AIDS cases in Philadelphia (6) were seen at a variety of sites.
Stage of illness and age may mediate the relation between socioeconomic status and survival period. Low socioeconomic status may result in patients being diagnosed with AIDS at either a later stage of illness (if they do not receive routine medical care) or an earlier stage (if they are not given prophylactic treatment and therefore develop an AIDS-defining opportunistic infection sooner than they otherwise would). Younger people are more likely to be of lower socioeconomic status and to have a longer survival period with HIV/AIDS (10, 15-20, 21, 27) . In the cohort study from Vancouver (5), income was not significantly associated with survival in bivariate analysis but was associated with survival after statistical adjustment for age and level of immune suppression. Poor nutrition, substandard housing, decreased social support, and exposure to violence may also explain differences in length of survival associated with socioeconomic status.
The disparate findings of the studies on socioeconomic status and HIV/AIDS survival may also reflect differences in measurement of socioeconomic status. In both the Vancouver cohort (5, 6) and the Baltimore HTV clinic (7) studies, patients' income was measured on the basis of self-report. Self-reported income data are subject to a number of biases and do not account for family size. The Philadelphia AIDS study used measures of income based on US census tracts (6); because census tracts are large, socioeconomic status can be heterogeneous (28, 29) .
To further evaluate the association, we studied the impact of socioeconomic status on length of survival among San Francisco, California, residents diagnosed with AIDS. Socioeconomic status was estimated using the census block group in which each person lived at the time of AIDS diagnosis. We examined the impact of socioeconomic status on length of survival across our population and assessed whether this impact was influenced by sex, age, ethnicity, HTV risk group, site of AIDS diagnosis, time period of AIDS diagnosis, or initial AIDS diagnosis.
MATERIALS AND METHODS

Study population
Between January 1, 1985, and December 31, 1995, 19,516 adult (aged >13 years) San Francisco residents were diagnosed with AIDS, and their diagnosis was reported as of December 31, 1996 . The AIDS diagnosis was based on the 1993 definition (30) . A recent study of the completeness and timeliness of reporting of AIDS cases found that in 1994, 89 percent of cases receiving care in a hospital setting were reported within 12 months and 96 percent were reported within 24 months (n = 527). Of those cases receiving care in a non-hospital-based clinic or a private physician's office (n -346), 85 percent were reported within 12 months and 90 percent were reported within 24 months (San Francisco Department of Public Health, unpublished data). In addition to AIDS reporting, we also learned of AIDS cases by reviewing all San Francisco death certificates. Of those cumulative AIDS cases reported from 1981 to 1996, 4 percent were identified using this method (San Francisco Department of Public Health, unpublished data).
Vital status for all patients in the registry was obtained in several ways. All San Francisco death certificates were reviewed to establish a date of death for AIDS cases. In addition, known AIDS cases were matched with the national death index. For cases not known to have died, follow-up information was obtained by reviewing laboratory and pathology logs and medical charts.
In this analysis, patients not known to have died were censored on the last date for which we had follow-up information or on December 31, 1996, whichever was earlier. Cases lost to follow-up prior to December 1994 were censored as of December 31, 1994 , to reflect the most current information available from the national death index.
For two major reasons, we chose to report survival based on all-cause mortality rather than on AIDS-specific mortality. First, this is standard in the literature on survival with AIDS. Second, it is not always possible to determine the true cause of death using a death certificate. Some physicians, intentionally or unintentionally, omit AIDS from the death certificate (31) . 
Socioeconomic status
To determine socioeconomic status, we first used Arc View software (Environmental Systems Research Institute Inc., Redlands, California) and 1990 census data to match each patient's address at the time of AIDS diagnosis to his or her census block group. A census block group is smaller than a census tract and is therefore more likely to be homogeneous with respect to socioeconomic status (28, 29) . On the basis of the socioeconomic indicators from the US Census Bureau Summary Tape File 3A and a sample edited detail file prepared by the Census Bureau for San Francisco, California, we categorized each block group according to three previously validated measures: poverty, predominantly working class neighborhood, and low educational level (28, 29) . A census block group was considered impoverished if ^20 percent of the population lived below the poverty line. A block group was classified as working class if ^66 percent of its employed residents were in censusdefined occupations that reflected subordinate positions at work. A block group was characterized by low educational level if >25 percent of those persons aged 25 years or older had not completed high school. The measures of poverty and educational level were race specific but the occupational measure was not, as the census does not stratify this variable by race.
A total of 185 persons lived in block groups for which the census reported no residents of the same ethnicity. Ninety-eight percent of these persons were ethnic minorities; they lived in block groups in which most residents' ethnicity differed from theirs. Since the census data on socioeconomic status were based on a sampling of households (one of every six), it is likely that these minorities were not sampled. We categorized them on the basis of the census block group as a whole. Fifty residents hved in one of two block groups with no employed residents. Both groups were categorized by poverty, although they were not characterized by low educational level. We categorized these two block groups as working class. Throughout the analysis, all three socioeconomic variables were treated as dichotomous and were moderately correlated: poverty and working class (r = 0.48), poverty and low educational level (r = 0.41), and working class and low educational level (r = 0.44). In reporting our analyses, we emphasized differences seen on at least two of the three measures of socioeconomic status and minimized our focus when variables differed on only one of the three.
Eighty-six patients were diagnosed at the county jail; 32 were homeless, 30 had an unknown or invalid address, and 24 had an address that could be geocoded. Our methodology did not allow us to determine a socioeconomic status for 515 homeless persons. They were therefore excluded from the main analysis. However, we did perform a supplementary analysis to assess how homelessness affected survival.
Additional predictor variables
Sex, age, ethnicity, HTV risk group, site of diagnosis, initial AIDS diagnosis, and time period of diagnosis were determined through medical chart review. In the analysis, site of initial AIDS diagnosis was categorized as one of the following: 1) public health hospital, public health clinic, community clinic, or jail; 2) federal or state hospital or clinic, which included a state university hospital and a Veterans Affairs hospital; 3) private hospital or private physician's office; or 4) outside of San Francisco. For the 2,769 cases diagnosed in 1994-1995, we ascertained insurance status for 2,609 (94.2 percent) at the time of AIDS diagnosis. (Information on insurance status was not uniformly collected prior to 1994.) Insurance status was categorized as 1) private insurance, including health maintenance organizations; 2) public insurance, including Medicare, Medicaid, and veterans benefits; or 3) no coverage. Time period of AIDS diagnosis was categorized as 1985-1988, 1989-1991, or 1992-1995. For the 7,451 AIDS cases diagnosed in 1992-1995, we also determined antiretroviral medication use (ever), Pneumocystis carinii pneumonia prophylaxis (ever), and CD4 count within 90 days of an AIDS diagnosis. Data on these three variables were available for 5,525 (74.2 percent) of the cases. Data on treatment and CD4 counts were more likely to be missing for persons diagnosed at sites outside of San Francisco (60.4 percent) or at private sites (29.0 percent) as compared with persons diagnosed at federal or state sites (22.0 percent) or at local public health sites (19.8 percent) . The pattern of missing data likely reflects the lower level of access that surveillance staff had to laboratory and treatment data at sites outside of San Francisco and at nonpublic sites.
Statistics
Median length of survival and cumulative probability of survival after an AIDS diagnosis were calculated using the Kaplan-Meier product limit method. Differences in survival period according to socioeconomic status were analyzed using log-rank statistics. Proportional hazards (Cox) regression was used to assess the association between survival and socioeconomic status after adjustment for potential intervening variables. All covariates were entered simultaneously into the multivariable model.
Review of the log-minus-log survival plots detected one covariate, an initial AIDS diagnosis of cryptosporidiosis, that appeared to depart significantly from the proportionality assumption. Therefore, we tested whether the relative hazard for cryptosporidiosis changed significantly during the study. A proportional hazards analysis was conducted using all of the covariates described above in addition to the three measures of socioeconomic status. In place of the covariate cryptosporidiosis (yes/no), we included two covariates: cryptosporidiosis in the first time period (yes/no) and cryptosporidiosis in the second time period (yes/no). The cutoff for the time period was chosen on the basis of the log-minus-log survival plot.
The relative hazards for these two variables were only marginally different (relative hazard (RH) = 1.09 vs. 1.91, p = 0.07). The other covariates, including the three socioeconomic status variables, were very similar to the model, with cryptosporidiosis disease as a single covariate. Therefore, this paper reports on the simpler model. All analyses were conducted using SAS software (Statistical Analysis System; SAS Institute, Inc., Carey, North Carolina).
RESULTS
Our analysis of the 19,516 adult (aged S13 years) San Francisco residents diagnosed with AIDS excluded 37 persons who were diagnosed by the medical examiner and 228 for whom we had no follow-up information after AIDS diagnosis. Of the remaining 19,251 cases, we determined a census block group for 18,167 (94.4 percent). Of the 1,084 persons for whom a census block group could not be assigned, 515 were homeless and 569 had an unknown or invalid San Francisco address.
The mean age of the sample was 39 years. The majority of AIDS cases were male, white, and men who had sex with men (table 1). The most common sites of initial AIDS diagnosis were a private hospital, a physician's office, and a public health hospital/ clinic/jail. Most AIDS cases were diagnosed in 1992-1995. The most common initial AIDS diagnoses were having a CD4 lymphocyte count of <200 cells or a CD4 percentage of <14 percent, P. carinii pneumonia, and Kaposi's sarcoma.
A total of 20.6 percent of cases lived in census block groups characterized by poverty, 29.4 percent in block groups characterized by working class occupations, and 18.7 percent in block groups characterized by low educational level (table 1) . Women, nonwhites, and heterosexual injecting drug users were more likely to be living in block groups characterized by low socioeconomic status. Persons diagnosed at public health hospitals/clinics/jail were more likely to live in census block groups characterized by low socioeconomic status than were those diagnosed at federal or state hospitals or clinics, at private facilities, and at sites outside of San Francisco. Among AIDS cases diagnosed in 1994-1995 and for whom we had information on health insurance, those with public insurance or no insurance were significantly more likely to live in census block groups characterized by a low socioeconomic status than were those with private insurance.
Initial AIDS diagnosis differed according to socioeconomic status. Persons with an AIDS indicator diagnosis of a CD4 count <200, wasting syndrome, candidiasis, cryptococcal disease, toxoplasmosis, or "other" were significantly more likely to be living in census block groups characterized by a low socioeconomic status. Patients diagnosed with P. carinii pneumonia, Kaposi's sarcoma, or non-Hodgkin's lymphoma were more likely to be living in census block groups characterized by a higher socioeconomic status.
Among those cases diagnosed in 1992-1995, the CD4 count at AIDS diagnosis did not differ across socioeconomic status groups. However, persons living in census block groups characterized by a higher socioeconomic status were more likely to be receiving antiretroviral treatment. Use of P. carinii pneumonia prophylaxis was also similar across measures of socioeconomic status.
Of the 18,167 AIDS cases studied, 13,287 (73.1 percent) had died by December 31, 1996, 4,246 (23.4 percent) were censored before the study ended, and 634 (3.5 percent) were known to be alive at the end of the study. The median length of follow-up for our sample was 19 months; for persons censored before the study ended, it was 28 monrns. There were only small differences by socioeconomic status in the proportion of subjects known to be dead, those censored before the study ended, and those known to be alive at the end of the study. For example, of those persons living in census block groups characterized by poverty, 70.3 percent had died, 24.9 percent were censored before the study ended, and 4.8 percent were known to be alive at the end of the study. Of those living in census block groups not characterized by poverty, the percentages were 73.9, 23.0, and 3.2, respectively.
The median length of survival of the sample was 23 months. Socioeconomic status did not affect median length of survival or survival at 1, 2, or 3 years (table  2) . The survival period was longer for women, for persons aged less than 50 years, for persons diagnosed in more recent years, and for persons diagnosed on the basis of a CD4 count <200 cells. The survival period was shorter for those diagnosed with an AIDSopportunistic infection or malignancy as compared with persons diagnosed on the basis of a CD4 count <200 cells or <14 percent. We repeated KaplanMeier analyses stratified first by sex and then by race/ethnicity. In these stratified models, socioeconomic status was not significantly associated with length of survival.
We performed proportional hazards analysis to assess whether socioeconomic status or other covariates were associated with mortality. Other covariates that were assessed were sex, age, ethnicity, HTV risk group, site of AIDS diagnosis, time period of AIDS diagnosis, and initial AIDS diagnosis (table 3) . None of the socioeconomic measures was associated with mortality. Length of survival was not associated with ethnicity or risk group. Being female was associated with a lower mortality, whereas age greater than 50 years was associated with a higher mortality. Persons diagnosed in 1989-1991 and 1992-1995 had a lower mortality than persons diagnosed in 1985-1988. As compared with persons diagnosed on the basis of a CD4 count <200 cells, persons diagnosed with other infections or malignancies had a higher mortality. We repeated our proportional hazards model, first stratifying by sex and then by ethnicity (rather than treating these variables as covariates). In these models, socioeconomic status was not associated with mortality.
Impact of antiretroviral and prophylactic therapy
To assess whether socioeconomic status may have affected survival in more recent years, during which antiretroviral and prophylactic therapy were introduced, we repeated the proportional hazards analysis stratified by time period of ADDS diagnosis and adjusted for all other covariates listed in table 3. None of the relative hazards for the socioeconomic measures was substantially different from 1.0 (RH, 0.93-1.12) during these three separate time periods.
To assess whether socioeconomic status would predict length of survival after adjustment for antiretroviral and prophylactic treatment and for CD4 count at the time of AIDS diagnosis, we repeated the proportional hazards analysis including these three variables for those patients diagnosed in 1992-1995. Living in a census block group characterized by low socioeconomic status was not associated with mortality. Both a higher CD4 count at the time of AIDS diagnosis and antiretroviral treatment were associated with a lower mortality (RH = 0.75, 95 percent Cl 0.73-0.77 and RH = 0.84, 95 percent Cl 0.76-0.93, respectively). However, P. carinii pneumonia prophylaxis was not significantly associated with length of survival (RH = 0.97, 95 percent Cl 0.89-1.06).
Homelessness
The 515 persons who were homeless when their AIDS was diagnosed were not included in the main models, because they had no address for which censusbased measures could be developed. However, we did assess their survival. Homeless persons had a significantly longer median survival time (29 months) than did housed persons (23 months). However, homelessness was significantly more common in 1992-1995 (4.6 percent) than in 1989-1991 (2.1 percent) or in 1985-1988 (0.7 percent). Since persons diagnosed in more recent years had significantly longer survival periods, we stratified the comparison of homeless with housed persons by time period of diagnosis. With stratification, the survival times of homeless and housed persons were found to be similar. In 1985 In , 1989 In -1991 , survival among homeless persons versus housed persons was 13 months versus 16 months, 20 months versus 22 months, and 32 months versus 31 months, respectively.
DISCUSSION
We found that socioeconomic status was not associated with length of survival among San Francisco residents with AIDS. Our results extend the findings of Chaisson et al. (7) to a population-based sample. While our study had the advantage of including all persons diagnosed with AIDS in San Francisco, regardless of where or whether they were receiving ongoing medical care, it had the disadvantage of using censusnlerived socioeconomic measures rather than individual-level variables. It is possible that if we had known the actual income of persons with AIDS, we would have observed an association between socioeconomic status and length of survival.
However, it is unlikely that we missed a true effect of socioeconomic status on length of survival. Our census-derived measures have been associated with hypothesized outcomes in prior studies (28, 29, 32) . Moreover, census-derived measures predict outcome even after adjustment for personal income (28, 33) , indicating that these variables contribute additional information about socioeconomic status. These measures of socioeconomic status worked well in our analysis. As would be expected, being female, nonwhite, and an injecting drug user were associated with a lower socioeconomic status. Persons characterized by a low socioeconomic status were significantly less likely to have private insurance or to be seen by private physicians and more likely to have public insurance or no insurance and to be seen in public hospitals and clinics. While the use of census-based measures has disadvantages, such measures are not subject to biased reporting or to family size.
Persons of low socioeconomic status and those of a higher socioeconomic status had similar CD4 counts at diagnosis in the years (1992-1995) for which CD4 counts were available. This finding suggests that it is unlikely that lead-time bias affected our results. Temporal changes in neighborhood composition (e.g., migration) during the 11-year period of our study may have resulted in misclassification. However, socioeconomic status did not predict length of survival when we limited the analysis to a narrow set of years. Since we used a person's address at the time of ADDS diagnosis, it is possible that some persons had already drifted down economically because of illness, disability, or unemployment (34, 35) . These persons would likely be sicker at the time of AIDS diagnosis and would have a shorter survival period. This would increase the likelihood that socioeconomic status would be associated with a short survival period, which was not our finding.
Several limitations of our study should be noted. The results might not apply to other cities. The San Francisco public health system is highly developed and focused on AIDS care; antiretroviral therapy and P. carinii pneumonia prophylaxis are provided to all patients, regardless of their ability to pay. Although we found that fewer persons of low socioeconomic status received antiretroviral drugs, as has been noted in other studies (22, 25, 36) , the magnitude of the differences was small (5-7 percent between those in the low and high socioeconomic groups). No differences were observed regarding receipt of P. carinii pneumonia therapy. In cities where indigent persons have less access to therapies, larger differences by socioeconomic status may exist. In addition, the effect of clinician experience on survival may be blunted in San Francisco, because the overall level of clinician experience with AIDS is high. Also, San Francisco has developed an extensive array of services for indigent persons with AIDS, including housing, food, and psychosocial counseling (37-39). These services, supported by local tax dollars and private donations, were available as early as 1982 (40) and were expanded in 1986 by the Health Resources and Services Administration demonstration project (41, 42) and in 1991 by the Ryan White (CARE) Act. To the extent that homelessness, poor nutrition, and ongoing substance abuse contribute to poor survival (4, 43) , these services may also mitigate the effect of low socioeconomic status.
Our data on race/ethnicity, antiretroviral therapy, and P. carinii pneumonia prophylaxis were limited because they were drawn from a review of medical charts. Race/ethnicity data from medical chart review are known to be subject to considerable misclassification (44) . A considerable amount of data on antiretroviral therapy and P. carinii pneumonia prophylaxis was missing, because this information is not always available from medical records. We were unable to assess potentially important effects of socioeconomic status on treatment, such as time lag in receiving new drug regimens, duration of use, and compliance with regimens.
Nonrandom censoring could also have biased our results. While 23.4 percent of cases were censored before the study ended, the median follow-up time for this group was substantial (28 months). There were only small differences in the proportion of subjects censored by socioeconomic status before the study ended. Another limitation of our study is that we were unable to restrict our analysis to AEDS-specific mortality. The leading causes of non-AIDS-related deaths in this population are accidents, suicide, and homicide (45) . These deaths are known to be more common among persons of a lower socioeconomic status (46) . Because we examined all-cause mortality, our data included persons who died of causes unrelated to HTV.
However, their inclusion in our study would tend to result in a shorter survival period among persons of a lower socioeconomic status. This was not the effect we found.
While socioeconomic status was not associated with length of survival during the years studied, this may change in the future. During the study period, zidovudine monotherapy was the most commonly prescribed regimen. Numerous studies have shown that the duration of the survival advantage due to zidovudine is limited (47) (48) (49) (50) . Because no more effective antiretroviral treatment was available, regardless of the ability to pay, access to treatment would not be expected to produce a major survival benefit. However, combination therapies developed after our study period, especially those that include protease inhibitors, appear to be much more powerful and may have more durable survival advantages than monotherapy with zidovudine (51) . Given these improvements in treatment efficacy, future differences in access to treatment would be expected to have a stronger effect on survival. It is also likely that future studies will demonstrate larger differences between socioeconomic status and access to treatment than those found in this study, because these newer treatments are more expensive and require more intensive medical management For example, the average yearly wholesale cost of a typical combination regimen of zidovudine, lamivudine, and indinavir is $12,310 versus $3,490 for zidovudine monotherapy (52) . Besides the cost and greater need for medical monitoring, these regimens are complicated-requiring frequent dosing at specific times of the day-and produce numerous drug interactions (51) . Persons characterized by a lower socioeconomic status may have more difficulty complying with these regimens.
It will be a major challenge for urban areas of the United States to provide access to these new treatment regimens. Public health systems that care for the majority of indigent AIDS cases (34, 53) will find it increasingly difficult to provide for these expensive treatments. Greater financial resources will be required to ensure that persons of a low socioeconomic status benefit fully from improvements in treatment. Use of census data to estimate socioeconomic status may help local areas to estimate the medical and social needs of their reported AIDS cases (54) and to assess how well the need for medical treatment is being fulfilled for persons of a low socioeconomic status.
